Galderma Group AG (GDERF)

OTCMKTS · Delayed Price · Currency is USD
112.20
-4.91 (-4.19%)
May 1, 2025, 4:00 PM EDT
Market Cap 27.64B
Revenue (ttm) 4.44B
Net Income (ttm) 231.00M
Shares Out n/a
EPS (ttm) 0.97
PE Ratio 119.63
Forward PE n/a
Dividend 0.18 (0.16%)
Ex-Dividend Date Apr 25, 2025
Volume 500
Average Volume 3,162
Open 112.20
Previous Close 117.11
Day's Range 112.20 - 112.20
52-Week Range 76.55 - 120.00
Beta n/a
RSI 57.87
Earnings Date Jul 24, 2025

About Galderma Group AG

Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services that span the spectrum of the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Dysport/Azzalure, Alluzience, Restylane, and Sculptra in injectable aesthetics; Cetaphil and Alastin in dermatological skincare; and Soolantra, Epiduo, Differin, Aklief, Epsolay, Twyneo, Oracea, Metvix, Benzac, and Loceryl in therapeutic ... [Read more]

Sector Healthcare
Founded 1981
Employees 6,545
Stock Exchange OTCMKTS
Ticker Symbol GDERF
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.